Open AccessVitamin D deficiency and COVID-19
Author(s) -
David C. Anderson,
David S Grimes
Publication year - 2020
Publication title -
clinical medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.531
H-Index - 56
eISSN - 1473-4893
pISSN - 1470-2118
DOI - 10.7861/clinmed.let.20.6.9
Subject(s) - covid-19 , medicine , pandemic , hypovitaminosis , betacoronavirus , coronavirus infections , vitamin d and neurology , vitamin d deficiency , intensive care medicine , virology , disease , outbreak , infectious disease (medical specialty)
Editor – Weir and colleagues timidly state that ‘If vitamin D does in fact reduce the severity of COVID-19 … [then] supplements would offer a relatively easy option to decrease the impact of the pandemic.’[1][1] This reticence ignores about 40 years of developing scientific knowledge of the
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom